Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.

Myers, Andrea P

Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer. [electronic resource] - International journal of cancer 07 2020 - 413-422 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1097-0215

10.1002/ijc.32783 doi


Adult
Aged
Class I Phosphatidylinositol 3-Kinases--genetics
Drug Administration Schedule
Endometrial Neoplasms--drug therapy
Female
Heterocyclic Compounds, 3-Ring--administration & dosage
Humans
Middle Aged
Mutation
Neoplasm Recurrence, Local--drug therapy
Precision Medicine
Treatment Outcome